Amneal to set up two plants with USD 200-mln investmentIllustrative image – not actual.

US-based Amneal Pharmaceuticals would invest up to USD 200 million (nearly Rs 1,680 crore) in India over the next four to five years to build two new manufacturing facilities in Ahmedabad, Gujarat. Of these two facilities planned, one will be for peptide synthesis and one for advanced sterile fill-finish manufacturing.

In this phase of expansion in India, Amneal will make a total net investment of between USD 150 million and USD 200 million to build two new greenfield facilities. With these new facilities, the company envisions to be at the forefront of developing and manufacturing innovative, branded medicines at scale in India, for supply in the local market and globally.

The company which started operations in India in 2008, currently has eight manufacturing sites, including five in Ahmedabad with additional sites in Dahej, Hyderabad and Vizag, and commercial offices in Mumbai. It has invested approx. USD 600 million in India over the past 10 years. These facilities have a collective capacity of producing up to approx. 60 million units of injectables and 8.5 billion tablets annually.

← All latest storiesBack to top →